Aerogenics India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 31-05-2024
- Paid Up Capital ₹ 0.10 M
as on 31-05-2024
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2019
- Revenue %
(FY 2019)
- Profit -1279.01%
(FY 2019)
- Ebitda 67.91%
(FY 2019)
- Net Worth -44.44%
(FY 2019)
- Total Assets 0.10%
(FY 2019)
About Aerogenics India
The Company is engaged in the Electrnoics Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Narasimha Apoori, Madhu Vaddi, Benadict Yennam, and Two other members serve as directors at the Company.
- CIN/LLPIN
U29309TG2017PTC114126
- Company No.
114126
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jan 2017
- Date of AGM
27 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aerogenics India?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narasimha Apoori  | Additional Director | 22-Jun-2017 | Current |
Madhu Vaddi  | Director | 18-Jan-2017 | Current |
| Benadict Yennam | Additional Director | 04-Feb-2019 | Current |
| Mohan Medepally | Director | 18-Jan-2017 | Current |
| Shachindar Gaddam | Additional Director | 22-Jun-2017 | Current |
Financial Performance and Corporate Structure Insights of Aerogenics India.
Aerogenics India Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1279.01% decrease in profit. The company's net worth observed a substantial decline by a decrease of 44.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aerogenics India?
Unlock access to Aerogenics India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Aegis Agro Chemicals (India) Private LimitedActive 12 years 4 months
Mohan Medepally is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aerogenics India?
Unlock and access historical data on people associated with Aerogenics India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aerogenics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aerogenics India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
